Orchard Therapeutics Company
Ex vivo gene therapy, rare diseases, personalised medicine, e.g. neurometabolic disorders.
Investors
.jpg)
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
2015
Employees Number:
101-250
Funding Status:
IPO
Investors Number:
24
Total Funding:
$310.5M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership